Next Article in Journal
Ethyl 5-Oxo-5-(((12-oxoindolo[2,1-b]quinazolin-6(12H)-ylidene)amino)oxy)pentanoate
Previous Article in Journal
Methyl-3-(3-hydroxy-3-(4-(piperidin-1-yl)phenyl)-prop-2-enoyl)benzoate
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

2-[Difluoro(phenylselenyl)methyl]benzo-1,3-thiazole

Jiangxi Provincial Key Laboratory of Functional Molecular Materials Chemistry, Faculty of Materials Metallurgy and Chemistry, Jiangxi University of Science and Technology, 86 Hongqi Road, Ganzhou 341000, China
*
Authors to whom correspondence should be addressed.
Molbank 2022, 2022(4), M1450; https://doi.org/10.3390/M1450
Submission received: 8 August 2022 / Revised: 14 September 2022 / Accepted: 15 September 2022 / Published: 22 September 2022
(This article belongs to the Section Organic Synthesis and Biosynthesis)

Abstract

:
This short note elaborates a concise protocol for the synthesis of 2-[difluoro(phenylselenyl)methyl]benzo-1,3-thiazole in two steps from the commercially available reagent 2-aminobenzenethiol. The structures of the synthesized compounds are confirmed by 1H-NMR, 13C-NMR and 19F-NMR spectroscopy, infrared (IR) spectra, and high-resolution mass spectrometry.

1. Introduction

The gem-difluoromethylene moiety has considerable characteristics in biochemistry and drug discovery; these are commonly known to be isostere for ethereal oxygen atoms and isopolar for carbonyl groups or lipophilic hydrogen bond donors [1,2]. The introduction of the gem-difluoromethylene moiety to bioactive molecules has become a privileged approach by changing the chemical, physical and biological properties of the molecules, slowing down the metabolic oxidation, restraining biodegradation and hydrolysis, and enhancing the lipophilicity and pharmacological activity of the molecules [3,4]. The importance of gem-difluoromethylene linked compounds has inspired chemists to develop mild and efficient construction methods. Thus far, significant advances have been made for the incorporation of the gem-difluoromethylene moiety in organic compounds [5,6]. On the other hand, heterocyclic compounds (with P, S, N atoms) related to natural products have been extensively studied because their important properties and applications, especially in biological activities such as anti-microbial, anti-proliferative (prostate cancer cells), anti-cancer, anti-influenza and anti-oxidant activity [7,8,9,10]. On account of containing substituents at C-2 position of benzo-1,3-thiazole compounds can effectively enhance the biological activities of these compounds [11]. Therefore, research into gem-difluoromethylene linked with benzo-1,3-thiazoles has great academic value and practical significance in the fields of pharmaceutical design and drug discovery.
2-(Bromodifluoromethyl)benzo-1,3-thiazole is an ideal benzo-1,3-thiazolic difluoromethylene radical source via metal catalytic or promoted single electron transfer processes [12]. Thus far, arylation reactions [13,14], alkylation reactions [12,15,16] and oxygen(sulfur) substitution reactions [17] involving 2-(bromodifluoromethyl)benzo-1,3-thiazole have been developed. On this basis, we report the copper-promoted reaction of 2-(bromodifluoromethyl)benzo-1,3-thiazole (1) with diphenyl diselenide to synthesize 2-[difluoro(phenylselenyl)methyl]benzo-1,3-thiazole (2).

2. Results

The title compound 2 was synthesized in a two-step procedure (Scheme 1) from the commercially available raw material 2-aminobenzenethiol. Firstly, 2-(bromodifluoromethyl)benzo-1,3-thiazole (1) was prepared by a condensation cyclization reaction of 2-aminobenzenethiol with bromodifluoroacetic acid [18]. The reaction went well, using chlorobenzene as a solvent to obtain compound 1 in 88% yield. Using one equivalent copper powder as a promoter, compound 1 reacts with diphenyl diselenide to obtain 2-[difluoro(phenylselenyl)methyl]benzo-1,3-thiazole (2) in 82% yield.
The molecular structure of compound 1 and 2 were both characterized by high-resolution mass spectrometry, 1H NMR, 13C NMR, and 19F NMR spectrometry.

3. Materials and Methods

All reagents were purchased from Shanghai Energy Chemical and used without further purification. NMR spectra were recorded on a Bruker Avance AV400 (400/100/376 MHz 1H/13C/19F) spectrometer (Bruker, Billerica, MA, USA) and chemical shifts (δ, ppm) were down-field from TMS. The infrared (IR) spectra were obtained in a Bruker Optics ALPHA FT-IR spectrometer using potassium bromide powder as supporter material. High-resolution MS data were obtained using a Thermo Scientific Q Exactive Orbitrap Mass Spectrometer. 1H NMR, 13C NMR and 19F NMR spectra of compounds 1, 2 are provided in the supplementary materials.
2-(Bromodifluoromethyl)benzo-1,3-thiazole (1) [17].
In a 25 mL Schlenk tube, bromodifluoroacetic acid (262 mg, 1.5 mmol) was added to the solution of 2-aminobenzenethiol (37.5 mg; 0.3 mmol) in chlorobenzene (3 mL). The reaction mixture was stirred at 100 °C for 18 h and then cooled to room temperature. We directly loaded the sample for column chromatography over silica gel (petroleum ether, Rf = 0.65) to obtain compound 1 in 88% yield (69.7 mg) as yellow oil. 1H NMR (400 MHz, CDCl3): δ, 8.19 (d, J = 8.0 Hz, 1H), 7.96 (d, J = 8.0 Hz, 1H), 7.62–7.58 (m, 1H), 7.56–7.51 (m, 1H); 13C NMR (100 MHz, CDCl3): δ 162.1 (t, J = 30.0 Hz, 1C), 151.8, 135.2, 127.4, 127.3, 125.0, 122.0, 113.4 (t, J = 300.0 Hz, 1C); 19F NMR (376 MHz, CDCl3): δ −43.31 (s, 2F).
2-[Difluoro(phenylselenyl)methyl]benzo-1,3-thiazole (2).
In a 25 mL Schlenk tube, compound 1 (78 mg, 0.3 mmol) was added to the solution of diphenyl diselenide (93 mg; 0.3 mmol) and Cu (19.2 mg, 0.3 mmol) in dry DMF (3 mL). The reaction mixture was stirred at 100 °C for 3 h and then cooled to room temperature. The reaction solution was washed with water and extracted with ethyl acetate, the collected organic phase was dried with anhydrous sodium sulfate, and then the organic phase removed the excess ethyl acetate by rotary evaporation. The residue was purified by column chromatography over silica gel (EtOAc/petroleum ether = 1/10, Rf = 0.30) to obtain compound 2 in 82% yield (83.6 mg) as a colorless powdery solid (recrystallized from EtOAc/petroleum ether, m. p. 88-90 °C). 1H NMR (400 MHz, CDCl3): δ 8.16 (d, J = 8.0 Hz, 1H), 7.92 (d, J = 8.0 Hz, 1H), 7.76 (d, J = 8.0 Hz, 2H), 7.58–7.55 (m, 1H), 7.51–7.47 (m, 1H), 7.45–7.42 (m, 1H), 7.37–7.33 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 163.3 (t, J = 30.0 Hz, 1C), 152.2, 137.5, 135.2, 130.0, 129.2, 126.9, 126.7, 124.6, 123.9, 121.9, 120.5 (t, J = 290.0 Hz, 1C); 19F NMR (376 MHz, CDCl3): δ −65.64 (s, 2F); IR (KBr): 3058, 1507, 1438, 1316, 1061, 1021, 873, 748, 689; HRMS (ESI): Exact mass calcd for C14H10F2NSSe [M + H]+: 341.9662, Found: 341.9654.

4. Conclusions

In conclusion, 2-[difluoro(phenylselenyl)methyl]benzo-1,3-thiazole was efficiently synthesized from 2-aminobenzenethiol in two steps and characterized by high-resolution mass spectrometry and NMR. The further application of the product is being explored in the laboratory.

Supplementary Materials

The following supporting information can be downloaded online, 1H NMR, 13C NMR and 19F NMR spectra of compounds 1, 2. Figure S1. 1H NMR, 13C NMR and 19F NMR spectra of compound 1. Figure S2. 1H NMR, 13C NMR and 19F NMR spectra of compound 2.

Author Contributions

R.X. prepared the compound and ran the spectra; Y.C. repeated the experiment and solved the structure; F.L. and J.L. designed the study, analyzed the data, and wrote the paper. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Jiangxi University of Science and Technology Doctoral Scientific Research Foundation, grant number JXXJBS18050.

Data Availability Statement

The data from this study are available in this paper and in its Supplementary Materials.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Welch, J.T.; Eswarakrishnan, S. Fluorine in Bioorganic Chemistry; Wiley: New York, NY, USA, 1991. [Google Scholar]
  2. Knust, H.; Achermann, G.; Ballard, T.; Buettelmann, B.; Gasser, R.; Fischer, H.; Hernandez, M.; Knoflach, F.; Koblet, A.; Stadler, H.; et al. The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA α5 inverse agonists for the treatment of cognitive dysfunction. Bioorg. Med. Chem. Lett. 2009, 19, 5940–5944. [Google Scholar] [CrossRef] [PubMed]
  3. O′Hagan, D. Understanding organofluorine chemistry. An introduction to the C-F bond. Chem. Soc. Rev. 2008, 37, 308–319. [Google Scholar] [CrossRef] [PubMed]
  4. Purser, S.; Moore, P.R.; Swallow, S.; Gouverneur, V. Fluorine in medicinal chemistry. Chem. Soc. Rev. 2008, 37, 320–330. [Google Scholar] [CrossRef] [PubMed]
  5. Feng, Z.; Xiao, Y.-L.; Zhang, X. Transition-metal (Cu, Pd, Ni)-catalyzed difluoroalkylation via cross-coupling with difluoroalkyl halides. Acc. Chem. Res. 2018, 51, 2264–2278. [Google Scholar] [CrossRef] [PubMed]
  6. Ni, C.; Zhu, L.; Hu, J. Advances in transition-metal-mediated di-and monofluoroalkylations. Huaxue Xuebao 2015, 73, 90–115. [Google Scholar] [CrossRef]
  7. Ott, I. On the medicinal chemistry of gold complexes as anticancer drugs. Coord. Chem. Rev. 2009, 253, 1670–1681. [Google Scholar] [CrossRef]
  8. Gasser, G.; Ott, I.; Metzler-Nolte, N. Organometallic anticancer compounds. J. Med. Chem. 2011, 54, 3–25. [Google Scholar] [CrossRef]
  9. Mihorianu, M.; Franz, M.H.; Jones, P.G.; Freytag, M.; Kelter, G.; Fiebig, H.H.; Tamm, M.; Neda, I. N-Heterocyclic carbenes derived from imidazo-[1,5-a]pyridines related to natural products: Synthesis, structure and potential biological activity of some corresponding gold(I) and silver(I) complexes. Appl. Organomet. Chem. 2016, 30, 581–589. [Google Scholar] [CrossRef]
  10. Vollbrecht, A.; Neda, I.; Thonnessen, H.; Jones, P.G.; Harris, R.K.; Crowe, L.A.; Schmutzler, R. Synthesis, structure, and reactivity of tetrakis(o,o-phosphorus)-bridged calix[4]resorcinols and their derivatives. Chem. Ber. 1997, 130, 1715–1720. [Google Scholar] [CrossRef]
  11. Reddy, P.V.G.; Lin, Y.-W.; Chang, H.-T. Synthesis of novel benzothiazole compounds with an extended conjugated system. Arkivoc 2007, 16, 113–122. [Google Scholar] [CrossRef]
  12. Jiang, H.; Xu, M.; Lu, W.; Tian, W.; Wan, W.; Chen, Y.; Deng, H.; Wu, S.; Hao, J. Direct gem-difluoromethylenation of sp3-hybridized carbon center through copper-mediated radical/radical cross-coupling for the construction of a CH2-CF2 linkage. Chem. Commun. 2015, 51, 15756–15759. [Google Scholar] [CrossRef] [PubMed]
  13. Jiang, H.; Lu, W.; Yang, K.; Ma, G.; Xu, M.; Li, J.; Yao, J.; Wan, W.; Deng, H.; Wu, S.; et al. Enhancement of neighbouring-group participation in Cu0-promoted cross-coupling gem-difluoromethylenation of aryl/alkenyl halides with 1,3-azolic difluoromethyl bromides. Chem.-A Eur. J. 2014, 20, 10084–10092. [Google Scholar] [CrossRef] [PubMed]
  14. Xiao, Y.-L.; Zhang, B.; Feng, Z.; Zhang, X. Heteroaryldifluoromethylation of organoborons catalyzed by palladium: Facile access to aryl(heteroaryl)difluoromethanes. Org. Lett. 2014, 16, 4822–4825. [Google Scholar] [CrossRef] [PubMed]
  15. Xu, C.; Yang, Z.-F.; An, L.; Zhang, X. Nickel-catalyzed difluoroalkylation-alkylation of enamides. ACS Catal. 2019, 9, 8224–8229. [Google Scholar] [CrossRef]
  16. Zhang, Q.; Wang, W.; Wang, P.; Deng, H.; Jiang, H. Copper-catalyzed aryldifluoromethylenation of N-arylacrylamides to synthesis of the diheterocyclic compounds linked by gem-difluoromethylene moiety. Tetrahedron 2019, 75, 130778. [Google Scholar] [CrossRef]
  17. Jiang, H.; Yuan, S.; Cai, Y.; Wan, W.; Zhu, S.; Hao, J. A facile preparation of 2-bromodifluoromethyl benzo-1,3-diazoles and its application in the synthesis of gem-difluoromethylene linked aryl ether compounds. J. Fluorine Chem. 2012, 133, 167–170. [Google Scholar] [CrossRef]
  18. Xu, R.; Liao, F.; Cai, Y.; Liu, J. A convenient synthesis of 2-bromodifluoromethyl benzo-1,3-thiazoles. Chin. J. Syn. Chem. 2022, 30, 588–592. [Google Scholar]
Scheme 1. Synthesis of 2-[difluoro(phenylselenyl)methyl]benzo-1,3-thiazole.
Scheme 1. Synthesis of 2-[difluoro(phenylselenyl)methyl]benzo-1,3-thiazole.
Molbank 2022 m1450 sch001
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Xu, R.; Cai, Y.; Liao, F.; Liu, J. 2-[Difluoro(phenylselenyl)methyl]benzo-1,3-thiazole. Molbank 2022, 2022, M1450. https://doi.org/10.3390/M1450

AMA Style

Xu R, Cai Y, Liao F, Liu J. 2-[Difluoro(phenylselenyl)methyl]benzo-1,3-thiazole. Molbank. 2022; 2022(4):M1450. https://doi.org/10.3390/M1450

Chicago/Turabian Style

Xu, Rongfu, Ying Cai, Fumin Liao, and Jinbiao Liu. 2022. "2-[Difluoro(phenylselenyl)methyl]benzo-1,3-thiazole" Molbank 2022, no. 4: M1450. https://doi.org/10.3390/M1450

APA Style

Xu, R., Cai, Y., Liao, F., & Liu, J. (2022). 2-[Difluoro(phenylselenyl)methyl]benzo-1,3-thiazole. Molbank, 2022(4), M1450. https://doi.org/10.3390/M1450

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop